https://news.medxy.ai/ja/%e9%96%80%e8%84%88%e8%85%ab%e7%98%8d%e6%a0%93%e3%82%92%e4%bc%b4%e3%81%86%e8%82%9d%e7%b4%b0%e8%83%9e%e7%99%8c%e3%81%ab%e5%af%be%e3%81%99%e3%82%8by90-radioembolization%ef%bc%9a%e8%82%9d%e7%a7%bb/Medxy AIja2026-06-03T21:53:34-07:00門脈腫瘍栓を伴う肝細胞癌に対するY90 radioembolization：肝移植への橋渡し治療 https://news.medxy.ai/vi/nut-mach-phong-xa-y90-cau-noi-toi-ghep-gan-trong-ung-thu-bieu-mo-te-bao-gan-kem-huyet-khoi-u-tinh-mach-cua/Medxy AIvi2026-06-03T21:53:11-07:00Nút mạch phóng xạ Y90: Cầu nối tới ghép gan trong ung thư biểu mô tế bào gan kèm huyết khối u tĩnh mạch cửa https://news.medxy.ai/y90-radioembolization-as-a-bridge-to-liver-transplantation-in-hepatocellular-carcinoma-with-portal-vein-tumor-thrombosis/Medxy AIen2026-06-03T21:52:28-07:00Y90 Radioembolization as a Bridge to Liver Transplantation in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis https://news.medxy.ai/zh/%e8%84%82%e8%82%aa%e7%bb%86%e8%83%9e%e9%a9%b1%e5%8a%a8%e7%9a%84%e8%83%b0%e8%85%ba%e7%99%8c%e5%85%8d%e7%96%ab%e4%bb%a3%e8%b0%a2%e6%8a%91%e5%88%b6%ef%bc%9a1213-dihome-ppar%ce%b3-tan-%e8%bd%b4/Medxy AIzh2026-06-03T21:02:31-07:00脂肪细胞驱动的胰腺癌免疫代谢抑制：12,13-DiHOME/PPARγ/TAN 轴 https://news.medxy.ai/ja/%e8%86%b5%e7%99%8c%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e8%84%82%e8%82%aa%e7%b4%b0%e8%83%9e%e4%b8%bb%e5%b0%8e%e3%81%ae%e5%85%8d%e7%96%ab%e4%bb%a3%e8%ac%9d%e6%8a%91%e5%88%b6%ef%bc%9a1213-dihome/Medxy AIja2026-06-03T21:02:10-07:00膵癌における脂肪細胞主導の免疫代謝抑制：12,13-DiHOME／PPARγ／TAN軸 https://news.medxy.ai/vi/ung-thu-tuy-va-truc-1213-dihome-ppar%ce%b3-tan-co-che-uc-che-mien-dich-do-te-bao-mo-dan-dat/Medxy AIvi2026-06-03T21:01:52-07:00Ung thư tụy và trục 12,13-DiHOME/PPARγ/TAN: cơ chế ức chế miễn dịch do tế bào mỡ dẫn dắt https://news.medxy.ai/adipocyte-driven-immunometabolic-suppression-in-pancreatic-cancer-the-1213-dihome-ppar%ce%b3-tan-axis/Medxy AIen2026-06-03T21:00:56-07:00Adipocyte-Driven Immunometabolic Suppression in Pancreatic Cancer: The 12,13-DiHOME/PPARγ/TAN Axis https://news.medxy.ai/ja/%e9%95%b7%e6%9c%9f%e7%bd%b9%e6%82%a3%e3%81%ae%e6%bd%b0%e7%98%8d%e6%80%a7%e5%a4%a7%e8%85%b8%e7%82%8e%e3%81%a7%e4%b8%8a%e6%98%87%e3%81%99%e3%82%8b%e3%82%af%e3%82%a9%e3%83%bc%e3%83%a9%e3%83%a0%e3%82%bb/Medxy AIja2026-06-03T18:23:37-07:00長期罹患の潰瘍性大腸炎で上昇するクォーラムセンシング分子、炎症性腸疾患関連癌への関与が示唆 https://news.medxy.ai/vi/cac-phan-tu-quorum-sensing-tang-cao-o-viem-loet-dai-trang-keo-dai-co-the-thuc-day-ung-thu-lien-quan-den-viem-dai-trang/Medxy AIvi2026-06-03T18:23:13-07:00Các phân tử quorum-sensing tăng cao ở viêm loét đại tràng kéo dài có thể thúc đẩy ung thư liên quan đến viêm đại tràng https://news.medxy.ai/quorum-sensing-molecules-elevated-in-long-standing-ulcerative-colitis-may-help-drive-colitis-associated-cancer/Medxy AIen2026-06-03T18:22:15-07:00Quorum-Sensing Molecules Elevated in Long-Standing Ulcerative Colitis May Help Drive Colitis-Associated Cancer https://news.medxy.ai/ja/aha%e6%8f%90%e5%94%b1%e3%81%ae%e3%81%8c%e3%82%93%e9%96%a2%e9%80%a3%e8%99%9a%e8%a1%80%e6%80%a7%e8%84%b3%e5%8d%92%e4%b8%ad%e5%88%86%e9%a1%9e%e3%82%92%e6%a4%9c%e8%a8%bc%e3%81%99%e3%82%8b%ef%bc%9a/Medxy AIja2026-06-03T12:41:48-07:00AHA提唱のがん関連虚血性脳卒中分類を検証する：再分類の実態と予後への影響 https://news.medxy.ai/vi/phan-loai-dot-quy-thieu-mau-cuc-bo-lien-quan-ung-thu-do-aha-de-xuat-tai-phan-loai-va-tac-dong-tien-luong/Medxy AIvi2026-06-03T12:41:11-07:00Phân loại đột quỵ thiếu máu cục bộ liên quan ung thư do AHA đề xuất: tái phân loại và tác động tiên lượng https://news.medxy.ai/application-of-the-aha-proposed-cancer-related-ischemic-stroke-classification-reclassification-and-prognostic-impact/Medxy AIen2026-06-03T12:40:09-07:00Application of the AHA-Proposed Cancer-Related Ischemic Stroke Classification: Reclassification and Prognostic Impact https://news.medxy.ai/midlife-central-obesity-tracks-with-higher-late-life-plasma-p-tau217-and-biomarker-verified-alzheimer-dementia-while-the-association-reverses-in-old-age/Medxy AIen2026-06-03T12:23:45-07:00Midlife Central Obesity Tracks With Higher Late-Life Plasma P-tau217 and Biomarker-Verified Alzheimer Dementia, While the Association Reverses in Old Age https://news.medxy.ai/ja/%e5%a4%a7%e8%a1%80%e7%ae%a1%e9%96%89%e5%a1%9e%e3%81%ab%e3%82%88%e3%82%8b%e6%80%a5%e6%80%a7%e8%99%9a%e8%a1%80%e6%80%a7%e8%84%b3%e5%8d%92%e4%b8%ad%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e6%a8%99%e6%ba%96/Medxy AIja2026-06-03T12:18:08-07:00大血管閉塞による急性虚血性脳卒中に対する標準用量テネクテプラーゼと低用量アルテプラーゼ：ランダム化臨床試験 https://news.medxy.ai/vi/tenecteplase-lieu-chuan-so-voi-alteplase-lieu-thap-trong-dot-quy-thieu-mau-nao-cap-do-tac-mach-mau-lon-thu-nghiem-lam-sang-ngau-nhien/Medxy AIvi2026-06-03T12:17:40-07:00Tenecteplase liều chuẩn so với alteplase liều thấp trong đột quỵ thiếu máu não cấp do tắc mạch máu lớn: thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/standard-dose-tenecteplase-vs-low-dose-alteplase-for-acute-ischemic-stroke-from-large-vessel-occlusion-a-randomized-clinical-trial-2/Medxy AIen2026-06-03T12:16:51-07:00Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion: A Randomized Clinical Trial https://news.medxy.ai/vi/tenecteplase-lieu-chuan-hay-alteplase-lieu-thap-lua-chon-nao-toi-uu-hon-cho-dot-quy-thieu-mau-cuc-bo-cap-do-tac-mach-mau-lon/Medxy AIvi2026-06-03T11:50:44-07:00Tenecteplase liều chuẩn hay alteplase liều thấp: lựa chọn nào tối ưu hơn cho đột quỵ thiếu máu cục bộ cấp do tắc mạch máu lớn? https://news.medxy.ai/standard-dose-tenecteplase-vs-low-dose-alteplase-for-acute-ischemic-stroke-from-large-vessel-occlusion-a-randomized-clinical-trial/Medxy AIen2026-06-03T11:49:53-07:00Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion: A Randomized Clinical Trial https://news.medxy.ai/new-genetic-modifiers-in-autosomal-dominant-alzheimers-disease-link-a%ce%b2-tau-tdp-43-and-vascular-biology-to-clinical-variability/Medxy AIen2026-06-03T11:41:47-07:00New Genetic Modifiers in Autosomal Dominant Alzheimer’s Disease Link Aβ, Tau, TDP-43, and Vascular Biology to Clinical Variability https://news.medxy.ai/detectable-antithyroglobulin-antibodies-above-the-assay-loq-signal-higher-recurrence-risk-in-papillary-thyroid-carcinoma-despite-undetectable-thyroglobulin/Medxy AIen2026-06-03T11:25:53-07:00Detectable Antithyroglobulin Antibodies Above the Assay LOQ Signal Higher Recurrence Risk in Papillary Thyroid Carcinoma Despite Undetectable Thyroglobulin https://news.medxy.ai/ja/%ce%b2%e7%b4%b0%e8%83%9e%e3%82%b0%e3%83%ab%e3%82%b3%e3%83%bc%e3%82%b9%e6%84%9f%e5%8f%97%e6%80%a7%e3%81%8c%e6%96%b0%e8%a6%8f%e7%99%ba%e7%97%871%e5%9e%8b%e7%b3%96%e5%b0%bf%e7%97%85%e6%b2%bb%e7%99%82/Medxy AIja2026-06-03T11:15:41-07:00β細胞グルコース感受性が新規発症1型糖尿病治療の反応予測に役立つ可能性 https://news.medxy.ai/vi/do-nhay-voi-glucose-cua-te-bao-beta-co-the-du-bao-dap-ung-voi-lieu-phap-cho-dai-thao-duong-tip-1-moi-khoi-phat/Medxy AIvi2026-06-03T11:15:20-07:00Độ nhạy với glucose của tế bào beta có thể dự báo đáp ứng với liệu pháp cho đái tháo đường típ 1 mới khởi phát https://news.medxy.ai/beta-cell-glucose-sensitivity-may-predict-response-to-new-onset-type-1-diabetes-therapies/Medxy AIen2026-06-03T11:14:34-07:00Beta Cell Glucose Sensitivity May Predict Response to New-Onset Type 1 Diabetes Therapies https://news.medxy.ai/zh/%e9%81%97%e4%bc%a0%e5%ad%a6%e8%af%81%e6%8d%ae%e8%bf%9b%e4%b8%80%e6%ad%a5%e8%af%81%e5%ae%9e%ef%bc%9a%e9%ab%98-bmi-%e6%98%af%e8%a1%80%e7%ae%a1%e6%80%a7%e7%97%b4%e5%91%86%e7%9a%84%e5%9b%a0%e6%9e%9c/Medxy AIzh2026-06-03T11:10:14-07:00遗传学证据进一步证实：高 BMI 是血管性痴呆的因果驱动因素，血压仅起部分中介作用 https://news.medxy.ai/ja/%e9%81%ba%e4%bc%9d%e5%ad%a6%e7%9a%84%e8%a8%bc%e6%8b%a0%e3%81%8c%e7%a4%ba%e3%81%99%ef%bc%9a%e9%ab%98bmi%e3%81%af%e8%a1%80%e7%ae%a1%e6%80%a7%e8%aa%8d%e7%9f%a5%e7%97%87%e3%81%ae%e5%9b%a0%e6%9e%9c/Medxy AIja2026-06-03T11:09:43-07:00遺伝学的証拠が示す：高BMIは血管性認知症の因果因子、血圧はその一部を仲介 https://news.medxy.ai/vi/bang-chung-di-truyen-cho-thay-bmi-cao-la-dong-luc-nhan-qua-cua-sa-sut-tri-tue-mach-mau-voi-huyet-ap-dong-vai-tro-trung-gian-mot-phan/Medxy AIvi2026-06-03T11:09:08-07:00Bằng chứng di truyền cho thấy BMI cao là động lực nhân quả của sa sút trí tuệ mạch máu, với huyết áp đóng vai trò trung gian một phần https://news.medxy.ai/genetic-evidence-strengthens-high-bmi-as-a-causal-driver-of-vascular-dementia-with-blood-pressure-as-a-partial-mediator/Medxy AIen2026-06-03T11:07:25-07:00Genetic Evidence Strengthens High BMI as a Causal Driver of Vascular Dementia, With Blood Pressure as a Partial Mediator https://news.medxy.ai/vi/ke-don-chinh-xac-thuoc-uc-che-sglt2-cho-dai-thao-duong-type-2-nham-phong-ngua-suy-tim-nguyen-phat/Medxy AIvi2026-06-03T10:35:28-07:00Kê đơn chính xác thuốc ức chế SGLT2 cho đái tháo đường type 2 nhằm phòng ngừa suy tim nguyên phát https://news.medxy.ai/precision-prescribing-of-sglt2-inhibitors-in-type-2-diabetes-for-primary-prevention-of-heart-failure/Medxy AIen2026-06-03T10:34:46-07:00Precision Prescribing of SGLT2 Inhibitors in Type 2 Diabetes for Primary Prevention of Heart Failure https://news.medxy.ai/bempedoic-acid-was-linked-to-fewer-venous-thromboembolic-events-in-statin-intolerant-patients-in-clear-outcomes/Medxy AIen2026-06-03T10:17:57-07:00Bempedoic Acid Was Linked to Fewer Venous Thromboembolic Events in Statin-Intolerant Patients in CLEAR Outcomes https://news.medxy.ai/thyroid-dysfunction-is-a-cardiovascular-risk-multiplier-but-treatment-benefits-depend-on-phenotype-severity-and-age/Medxy AIen2026-06-03T09:44:02-07:00Thyroid Dysfunction Is a Cardiovascular Risk Multiplier, but Treatment Benefits Depend on Phenotype, Severity, and Age https://news.medxy.ai/ja/%e5%bf%83%e4%b8%8d%e5%85%a8%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e9%80%a3%e7%b6%9a%e3%83%a2%e3%83%8b%e3%82%bf%e3%83%aa%e3%83%b3%e3%82%b0%e4%b8%8b%e3%81%ae%e4%b8%8d%e6%95%b4%e8%84%88%e8%b2%a0%e8%8d%b7/Medxy AIja2026-06-03T09:39:35-07:00心不全における連続モニタリング下の不整脈負荷と臨床反応：ALLEVIATE-HF試験からの所見 https://news.medxy.ai/vi/ganh-nang-loan-nhip-va-dap-ung-lam-sang-khi-theo-doi-lien-tuc-o-benh-nhan-suy-tim-quan-sat-tu-thu-nghiem-alleviate-hf/Medxy AIvi2026-06-03T09:39:09-07:00Gánh nặng loạn nhịp và đáp ứng lâm sàng khi theo dõi liên tục ở bệnh nhân suy tim: Quan sát từ thử nghiệm ALLEVIATE-HF https://news.medxy.ai/arrhythmia-burden-and-clinical-responses-under-continuous-monitoring-in-heart-failure-observations-from-the-alleviate-hf-trial/Medxy AIen2026-06-03T09:38:17-07:00Arrhythmia Burden and Clinical Responses Under Continuous Monitoring in Heart Failure: Observations From the ALLEVIATE-HF Trial https://news.medxy.ai/zh/%e5%87%8f%e9%87%8d%e5%b9%b6%e9%9d%9e%e5%94%af%e4%b8%80%e5%85%b3%e9%94%ae%ef%bc%9a%e5%86%85%e8%84%8f%e8%84%82%e8%82%aa%e5%87%8f%e5%b0%91%e6%88%96%e6%98%af%e9%95%bf%e6%9c%9f%e5%bf%83%e4%bb%a3%e8%b0%a2/Medxy AIzh2026-06-03T09:35:45-07:00减重并非唯一关键：内脏脂肪减少或是长期心代谢健康更稳固的靶点 https://news.medxy.ai/ja/%e4%bd%93%e9%87%8d%e6%b8%9b%e5%b0%91%e3%81%a0%e3%81%91%e3%81%a7%e3%81%af%e4%b8%8d%e5%8d%81%e5%88%86%ef%bc%9f-%e9%95%b7%e6%9c%9f%e7%9a%84%e3%81%aa%e5%bf%83%e4%bb%a3%e8%ac%9d%e3%81%ae%e5%81%a5%e5%ba%b7/Medxy AIja2026-06-03T09:35:13-07:00体重減少だけでは不十分？ 長期的な心代謝の健康には内臓脂肪の減少がより重要かもしれない https://news.medxy.ai/vi/giam-mo-tang-chu-khong-chi-giam-can-muc-tieu-ben-vung-hon-cho-suc-khoe-tim-mach-chuyen-hoa-lau-dai/Medxy AIvi2026-06-03T09:34:37-07:00Giảm mỡ tạng, chứ không chỉ giảm cân: Mục tiêu bền vững hơn cho sức khỏe tim mạch-chuyển hóa lâu dài https://news.medxy.ai/visceral-fat-loss-not-weight-loss-alone-may-be-the-more-durable-target-for-long-term-cardiometabolic-health/Medxy AIen2026-06-03T09:32:54-07:00Visceral Fat Loss, Not Weight Loss Alone, May Be the More Durable Target for Long-Term Cardiometabolic Health https://news.medxy.ai/ja/%e9%80%b2%e8%a1%8c%e4%b9%b3%e7%99%8c%e3%81%ae%e5%88%9d%e5%9b%9e%e6%b2%bb%e7%99%82%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8bfovinaciclib%ef%bc%9a%e3%83%a9%e3%83%b3%e3%83%80%e3%83%a0%e5%8c%96%e8%87%a8/Medxy AIja2026-06-03T09:29:03-07:00進行乳癌の初回治療におけるfovinaciclib：ランダム化臨床試験 https://news.medxy.ai/vi/fovinaciclib-trong-dieu-tri-hang-dau-dong-dau-tay-ung-thu-vu-tien-trien-ket-qua-tu-mot-thu-nghiem-lam-sang-ngau-nhien/Medxy AIvi2026-06-03T09:28:37-07:00Fovinaciclib trong điều trị hàng đầu dòng đầu tay ung thư vú tiến triển: Kết quả từ một thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/fovinaciclib-for-first-line-therapy-of-advanced-breast-cancer-a-randomized-clinical-trial/Medxy AIen2026-06-03T09:27:48-07:00Fovinaciclib for First-Line Therapy of Advanced Breast Cancer: A Randomized Clinical Trial https://news.medxy.ai/ja/%e3%81%86%e3%81%a4%e7%97%85%e3%81%ab%e5%af%be%e3%81%99%e3%82%8bmst%e3%81%a8%e5%8f%b3%e7%89%87%e5%81%b4%e8%b6%85%e7%9f%ad%e3%83%91%e3%83%ab%e3%82%b9ect%e3%81%ae%e6%9c%89%e5%8a%b9%e6%80%a7%e3%83%bb/Medxy AIja2026-06-03T00:21:44-07:00うつ病に対するMSTと右片側超短パルスECTの有効性・安全性を検証した確認試験 https://news.medxy.ai/vi/thu-nghiem-xac-nhan-ve-hieu-qua-va-do-an-toan-cua-lieu-phap-co-giat-tu-truong-so-voi-ect-mot-ben-phai-xung-sieu-ngan-trong-dieu-tri-tram-cam/Medxy AIvi2026-06-03T00:21:20-07:00Thử nghiệm xác nhận về hiệu quả và độ an toàn của liệu pháp co giật từ trường so với ECT một bên phải, xung siêu ngắn trong điều trị trầm cảm https://news.medxy.ai/confirmatory-efficacy-and-safety-trial-of-magnetic-seizure-therapy-versus-right-unilateral-ultra-brief-electroconvulsive-therapy-in-depression/Medxy AIen2026-06-03T00:20:35-07:00Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy Versus Right Unilateral Ultra-Brief Electroconvulsive Therapy in Depression https://news.medxy.ai/ja/%e3%81%86%e3%81%a4%e7%97%85%e6%b2%bb%e7%99%82%e3%81%ae%e6%96%b0%e3%81%9f%e3%81%aa%e6%a8%99%e7%9a%84%ef%bc%9a%e3%82%a4%e3%83%b3%e3%82%bf%e3%83%bc%e3%83%ad%e3%82%a4%e3%82%ad%e3%83%b36%e9%81%ae%e6%96%ad/Medxy AIja2026-06-03T00:02:53-07:00うつ病治療の新たな標的：インターロイキン6遮断を検証した概念実証無作為化臨床試験 https://news.medxy.ai/vi/tocilizumab-nham-vao-il-6-trien-vong-moi-trong-dieu-tri-tram-cam-lien-quan-viem/Medxy AIvi2026-06-03T00:02:29-07:00Tocilizumab nhắm vào IL-6: triển vọng mới trong điều trị trầm cảm liên quan viêm https://news.medxy.ai/interleukin-6-as-a-treatment-target-for-depression-a-proof-of-concept-randomized-clinical-trial/Medxy AIen2026-06-03T00:01:40-07:00Interleukin 6 as a Treatment Target for Depression: A Proof-of-Concept Randomized Clinical Trial https://news.medxy.ai/zh/%e9%87%8d%e6%96%b0%e5%ae%a1%e8%a7%86%e5%bf%83%e8%84%8f%e5%a4%96%e7%a7%91%e6%9c%af%e5%90%8e%e6%88%bf%e9%a2%a4%e7%9a%84%e9%95%81%e9%a2%84%e9%98%b2%ef%bc%9a%e4%b8%b4%e5%ba%8a%e8%af%81%e6%8d%ae%e7%9a%84/Medxy AIzh2026-06-02T23:59:57-07:00重新审视心脏外科术后房颤的镁预防：临床证据的综合分析 https://news.medxy.ai/ja/%e5%bf%83%e8%87%93%e6%89%8b%e8%a1%93%e5%be%8c%e3%81%ae%e8%a1%93%e5%be%8c%e5%bf%83%e6%88%bf%e7%b4%b0%e5%8b%95%e4%ba%88%e9%98%b2%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e3%83%9e%e3%82%b0%e3%83%8d%e3%82%b7/Medxy AIja2026-06-02T23:59:40-07:00心臓手術後の術後心房細動予防におけるマグネシウム投与を再考する：臨床エビデンスの統合 https://news.medxy.ai/vi/xem-xet-lai-du-phong-bang-magie-doi-voi-rung-nhi-sau-phau-thuat-trong-phau-thuat-tim-tong-hop-bang-chung-lam-sang/Medxy AIvi2026-06-02T23:59:19-07:00Xem xét lại dự phòng bằng magiê đối với rung nhĩ sau phẫu thuật trong phẫu thuật tim: Tổng hợp bằng chứng lâm sàng https://news.medxy.ai/rethinking-magnesium-prophylaxis-for-postoperative-atrial-fibrillation-in-cardiac-surgery-a-synthesis-of-clinical-evidence/Medxy AIen2026-06-02T23:58:00-07:00Rethinking Magnesium Prophylaxis for Postoperative Atrial Fibrillation in Cardiac Surgery: A Synthesis of Clinical Evidence https://news.medxy.ai/extracorporeal-cpr-may-improve-survival-after-pediatric-out-of-hospital-cardiac-arrest-but-evidence-remains-early/Medxy AIen2026-06-02T22:07:15-07:00Extracorporeal CPR May Improve Survival After Pediatric Out-of-Hospital Cardiac Arrest, but Evidence Remains Early https://news.medxy.ai/vi/ecpr-ngoai-co-the-trong-ngung-tim-ngoai-benh-vien-o-tre-em/Medxy AIvi2026-06-02T22:06:01-07:00ECPR ngoài cơ thể trong ngừng tim ngoài bệnh viện ở trẻ em https://news.medxy.ai/extracorporeal-cardiopulmonary-resuscitation-for-pediatric-out-of-hospital-cardiac-arrest/Medxy AIen2026-06-02T22:05:20-07:00Extracorporeal Cardiopulmonary Resuscitation for Pediatric Out-of-Hospital Cardiac Arrest https://news.medxy.ai/ja/%e8%82%a1%e9%96%a2%e7%af%80%e3%83%bb%e8%86%9d%e9%96%a2%e7%af%80%e7%bd%ae%e6%8f%9b%e8%a1%93%e5%be%8c%e3%81%ae%e6%8a%97%e5%87%9d%e5%9b%ba%e7%99%82%e6%b3%95%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e6%82%a3/Medxy AIja2026-06-02T22:03:22-07:00股関節・膝関節置換術後の抗凝固療法における患者選好の類型 https://news.medxy.ai/vi/ba-kieu-uu-tien-cua-benh-nhan-khi-dung-thuoc-chong-dong-sau-thay-khop-hang-hoac-khop-goi/Medxy AIvi2026-06-02T22:02:58-07:00Ba kiểu ưu tiên của bệnh nhân khi dùng thuốc chống đông sau thay khớp háng hoặc khớp gối https://news.medxy.ai/patient-preference-phenotypes-for-post-operative-anticoagulation-after-hip-or-knee-replacement/Medxy AIen2026-06-02T22:02:17-07:00Patient Preference Phenotypes for Post-operative Anticoagulation After Hip or Knee Replacement https://news.medxy.ai/patient-preference-phenotypes-for-post-operative-anticoagulation-after-hip-or-knee-replacement-a-cross-sectional-survey-study/Medxy AIen2026-06-02T20:13:26-07:00Patient Preference Phenotypes for Post-operative Anticoagulation After Hip or Knee Replacement: A Cross-sectional Survey Study https://news.medxy.ai/ja/%e5%8c%bb%e7%99%82%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e3%83%97%e3%83%a9%e3%82%a4%e3%83%99%e3%83%bc%e3%83%88%e3%83%bb%e3%82%a8%e3%82%af%e3%82%a4%e3%83%86%e3%82%a3%e3%81%a8%e4%bc%81%e6%a5%ad%e5%8c%96/Medxy AIja2026-06-02T19:50:05-07:00医療におけるプライベート・エクイティと企業化の規制枠組み：ACPポジションペーパー https://news.medxy.ai/vi/khung-phap-ly-doi-voi-private-equity-va-doanh-nghiep-hoa-trong-cham-soc-suc-khoe-quan-diem-cua-acp/Medxy AIvi2026-06-02T19:49:40-07:00Khung pháp lý đối với private equity và doanh nghiệp hóa trong chăm sóc sức khỏe: Quan điểm của ACP https://news.medxy.ai/regulatory-framework-for-private-equity-and-corporatization-in-health-care-an-acp-position-paper/Medxy AIen2026-06-02T19:48:51-07:00Regulatory Framework for Private Equity and Corporatization in Health Care: An ACP Position Paper https://news.medxy.ai/ja/%e5%90%8c%e7%a8%ae%e9%80%a0%e8%a1%80%e5%b9%b9%e7%b4%b0%e8%83%9e%e7%a7%bb%e6%a4%8d%e5%be%8c%e3%81%ae%e6%97%a9%e6%9c%9f%e9%ab%98%e8%a7%a3%e5%83%8f%e5%ba%a6%e5%85%8d%e7%96%ab%e3%83%97%e3%83%ad%e3%83%95/Medxy AIja2026-06-02T17:02:44-07:00同種造血幹細胞移植後の早期高解像度免疫プロファイルは生存と再発を左右する https://news.medxy.ai/vi/ho-so-mien-dich-do-phan-giai-cao-giai-doan-som-lien-quan-den-song-con-va-tai-phat-sau-ghep-te-bao-goc-di-gen/Medxy AIvi2026-06-02T17:02:22-07:00Hồ sơ miễn dịch độ phân giải cao giai đoạn sớm liên quan đến sống còn và tái phát sau ghép tế bào gốc dị gen https://news.medxy.ai/early-high-resolution-immune-profiles-are-linked-to-survival-and-relapse-after-allogeneic-stem-cell-transplantation/Medxy AIen2026-06-02T17:01:38-07:00Early High-Resolution Immune Profiles Are Linked to Survival and Relapse After Allogeneic Stem Cell Transplantation https://news.medxy.ai/zh/%e6%af%8f%e5%91%a8%e4%b8%a4%e6%ac%a1%e5%85%a8%e5%8f%a3%e6%9c%8d-ixazomib%e3%80%81pomalidomide-%e8%81%94%e5%90%88-dexamethasone-%e5%9c%a8%e5%a4%8d%e5%8f%91-%e9%9a%be%e6%b2%bb%e6%80%a7%e5%a4%9a%e5%8f%91/Medxy AIzh2026-06-02T12:58:02-07:00每周两次全口服 ixazomib、pomalidomide 联合 dexamethasone 在复发/难治性多发性骨髓瘤中显示持久疗效 https://news.medxy.ai/ja/%e5%86%8d%e7%99%ba%e3%83%bb%e9%9b%a3%e6%b2%bb%e6%80%a7%e5%a4%9a%e7%99%ba%e6%80%a7%e9%aa%a8%e9%ab%84%e8%85%ab%e3%81%ab%e3%81%8a%e3%81%84%e3%81%a6%e3%80%81%e9%80%b12%e5%9b%9e%e3%81%ae%e5%ae%8c%e5%85%a8/Medxy AIja2026-06-02T12:57:07-07:00再発・難治性多発性骨髄腫において、週2回の完全経口イキサゾミブ＋ポマリドミド＋デキサメタゾンが持続的な有効性を示す https://news.medxy.ai/vi/ixazomib-pomalidomide-va-dexamethasone-duong-uong-hai-lan-moi-tuan-cho-thay-hieu-qua-ben-vung-o-da-u-tuy-tai-phat-khang-tri/Medxy AIvi2026-06-02T12:56:31-07:00Ixazomib, Pomalidomide và Dexamethasone đường uống hai lần mỗi tuần cho thấy hiệu quả bền vững ở đa u tủy tái phát/kháng trị https://news.medxy.ai/twice-weekly-all-oral-ixazomib-pomalidomide-and-dexamethasone-shows-durable-activity-in-relapsed-refractory-multiple-myeloma/Medxy AIen2026-06-02T12:54:49-07:00Twice-Weekly All-Oral Ixazomib, Pomalidomide, and Dexamethasone Shows Durable Activity in Relapsed/Refractory Multiple Myeloma https://news.medxy.ai/ja/b%e7%b4%b0%e8%83%9e%e6%80%a5%e6%80%a7%e3%83%aa%e3%83%b3%e3%83%91%e6%80%a7%e7%99%bd%e8%a1%80%e7%97%85%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8bcd19-cd22%e4%ba%8c%e9%87%8d%e6%a8%99%e7%9a%84car-t%e7%b4%b0/Medxy AIja2026-06-02T12:01:11-07:00B細胞急性リンパ性白血病におけるCD19/CD22二重標的CAR T細胞療法後再発の細胞・分子機序 https://news.medxy.ai/vi/hieu-co-che-tai-phat-sau-lieu-phap-car-t-nham-dich-kep-cd19-cd22-trong-b-all/Medxy AIvi2026-06-02T12:00:53-07:00Hiểu cơ chế tái phát sau liệu pháp CAR T nhắm đích kép CD19/CD22 trong B-ALL https://news.medxy.ai/cellular-and-molecular-mechanisms-of-relapse-after-cd19-cd22-dual-target-car-t-cell-therapy-in-b-cell-acute-lymphoblastic-leukemia/Medxy AIen2026-06-02T12:00:15-07:00Cellular and Molecular Mechanisms of Relapse After CD19/CD22 Dual-Target CAR T-Cell Therapy in B-Cell Acute Lymphoblastic Leukemia https://news.medxy.ai/anti-cd117-conditioning-with-briquilimab-shows-feasibility-and-stem-cell-depletion-in-older-adults-undergoing-allogeneic-transplant-for-high-risk-aml-and-mds/Medxy AIen2026-06-02T11:44:17-07:00Anti-CD117 Conditioning With Briquilimab Shows Feasibility and Stem-Cell Depletion in Older Adults Undergoing Allogeneic Transplant for High-Risk AML and MDS https://news.medxy.ai/zh/ct%e5%b0%8f%e5%8a%a8%e8%84%89%e5%87%8f%e5%b0%91%e6%af%94%e8%82%ba%e5%ae%9e%e8%b4%a8%e6%8d%9f%e4%bc%a4%e6%9b%b4%e8%83%bd%e6%8f%90%e7%a4%bacopd%e4%b8%8e%e7%ba%a4%e7%bb%b4%e5%8c%96%e6%80%a7ild%e4%b8%ad/Medxy AIzh2026-06-02T09:23:14-07:00CT小动脉减少比肺实质损伤更能提示COPD与纤维化性ILD中的重度肺动脉高压 https://news.medxy.ai/ja/copd%e3%81%a8%e7%b7%9a%e7%b6%ad%e5%8c%96%e6%80%a7ild%e3%81%ae%e9%87%8d%e7%97%87%e8%82%ba%e9%ab%98%e8%a1%80%e5%9c%a7%e7%97%87%e3%82%92%e6%98%a0%e3%81%99ct%e8%a1%80%e7%ae%a1%e6%8c%87%e6%a8%99%e2%80%95/Medxy AIja2026-06-02T09:22:42-07:00COPDと線維化性ILDの重症肺高血圧症を映すCT血管指標――実質障害より鋭敏な小動脈減少の評価 https://news.medxy.ai/vi/ct-cho-thay-mat-dong-mach-nho-lien-quan-chat-voi-tang-ap-dong-mach-phoi-nang-o-copd-va-ild-xo-hoa-hon-la-ton-thuong-nhu-mo/Medxy AIvi2026-06-02T09:22:04-07:00CT cho thấy mất động mạch nhỏ liên quan chặt với tăng áp động mạch phổi nặng ở COPD và ILD xơ hóa hơn là tổn thương nhu mô https://news.medxy.ai/ct-small-artery-loss-tracks-severe-pulmonary-hypertension-in-copd-and-fibrosing-ild-more-closely-than-parenchymal-damage/Medxy AIen2026-06-02T09:20:07-07:00CT Small-Artery Loss Tracks Severe Pulmonary Hypertension in COPD and Fibrosing ILD More Closely Than Parenchymal Damage https://news.medxy.ai/ja/%e9%9b%bb%e5%ad%90%e9%bc%bb%e3%81%af%e7%b7%9a%e7%b6%ad%e6%80%a7%e9%96%93%e8%b3%aa%e6%80%a7%e8%82%ba%e7%96%be%e6%82%a3%e3%82%92%e8%a6%8b%e5%88%86%e3%81%91%e3%82%89%e3%82%8c%e3%82%8b%e3%81%8b%e3%80%80/Medxy AIja2026-06-02T09:16:46-07:00電子鼻は線維性間質性肺疾患を見分けられるか　国際検証で示された診断支援の可能性 https://news.medxy.ai/vi/xac-thuc-quoc-te-cong-nghe-mui-dien-tu-trong-chan-doan-benh-phoi-ke-xo-hoa/Medxy AIvi2026-06-02T09:16:23-07:00Xác thực quốc tế công nghệ mũi điện tử trong chẩn đoán bệnh phổi kẽ xơ hóa https://news.medxy.ai/international-validation-of-electronic-nose-technology-as-a-diagnostic-tool-for-fibrotic-interstitial-lung-diseases-2/Medxy AIen2026-06-02T09:15:39-07:00International Validation of Electronic Nose Technology as a Diagnostic Tool for Fibrotic Interstitial Lung Diseases https://news.medxy.ai/international-validation-of-electronic-nose-technology-as-a-diagnostic-tool-for-fibrotic-interstitial-lung-diseases/Medxy AIen2026-06-02T09:09:34-07:00International Validation of Electronic Nose Technology as a Diagnostic Tool for Fibrotic Interstitial Lung Diseases https://news.medxy.ai/ja/%e5%be%ae%e5%b0%8f%e8%a1%80%e7%ae%a1%e6%b6%88%e5%a4%b1%e3%81%ae%e6%9c%89%e7%84%a1%e3%81%a7%e3%81%bf%e3%82%8b%e5%89%8d%e8%a6%96%e9%87%8e%e7%b7%91%e5%86%85%e9%9a%9c%e3%81%ae%e9%80%b2%e8%a1%8c%e4%ba%88/Medxy AIja2026-06-02T09:05:11-07:00微小血管消失の有無でみる前視野緑内障の進行予測 https://news.medxy.ai/vi/glocom-tien-thi-truong-mat-vi-mach-nen-du-bao-tien-trien-nhanh-hon-va-nguy-co-ton-thuong-thi-truong-cao-hon/Medxy AIvi2026-06-02T09:04:50-07:00Glôcôm tiền thị trường: mất vi mạch nền dự báo tiến triển nhanh hơn và nguy cơ tổn thương thị trường cao hơn https://news.medxy.ai/progression-in-preperimetric-glaucoma-eyes-with-and-without-microvasculature-dropout-2/Medxy AIen2026-06-02T09:04:03-07:00Progression in Preperimetric Glaucoma Eyes With and Without Microvasculature Dropout https://news.medxy.ai/vi/tien-trien-o-mat-glocom-tien-thi-truong-co-va-khong-co-mat-vi-mach/Medxy AIvi2026-06-02T08:17:19-07:00Tiến triển ở mắt glôcôm tiền thị trường có và không có mất vi mạch https://news.medxy.ai/progression-in-preperimetric-glaucoma-eyes-with-and-without-microvasculature-dropout/Medxy AIen2026-06-02T08:16:22-07:00Progression in Preperimetric Glaucoma Eyes With and Without Microvasculature Dropout